Citranatal 90 Dha

Vitamin C, Calcium, Iron, Vitamin D3, Vitamin E, Thiamin, Riboflavin, Niacinamide, Vitamin B6, Folic Acid, Iodine, Zinc, Copper, Docusate Sodium

Mission Pharmacal Company
Human Prescription Drug
NDC 0178-0821

Citranatal 90 Dha also known as Vitamin C, Calcium, Iron, Vitamin D3, Vitamin E, Thiamin, Riboflavin, Niacinamide, Vitamin B6, Folic Acid, Iodine, Zinc, Copper, Docusate Sodium is a human prescription drug labeled by 'Mission Pharmacal Company'. National Drug Code (NDC) number for Citranatal 90 Dha is 0178-0821. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Citranatal 90 Dha drug includes .alpha.-tocopherol Acetate - 30 [iU]/1 Ascorbic Acid - 120 mg/1 Calcium Citrate - 159 mg/1 Cupric Oxide - 2 mg/1 Docusate Sodium - 50 mg/1 Ferrous Gluconate - 5 mg/1 Folic Acid - 1 mg/1 Iron - 85 mg/1 Niacinamide - 20 mg/1 Potassium Iodide - 150 ug/1 and more. The currest status of Citranatal 90 Dha drug is Active.

Drug Information:

Drug NDC:	0178-0821
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Citranatal 90 Dha
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Vitamin C, Calcium, Iron, Vitamin D3, Vitamin E, Thiamin, Riboflavin, Niacinamide, Vitamin B6, Folic Acid, Iodine, Zinc, Copper, Docusate Sodium
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Mission Pharmacal Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	.ALPHA.-TOCOPHEROL ACETATE - 30 [iU]/1 ASCORBIC ACID - 120 mg/1 CALCIUM CITRATE - 159 mg/1 CUPRIC OXIDE - 2 mg/1 DOCUSATE SODIUM - 50 mg/1 FERROUS GLUCONATE - 5 mg/1 FOLIC ACID - 1 mg/1 IRON - 85 mg/1 NIACINAMIDE - 20 mg/1 POTASSIUM IODIDE - 150 ug/1 Load more... PYRIDOXINE HYDROCHLORIDE - 20 mg/1 RIBOFLAVIN - 3.4 mg/1 THIAMINE - 3 mg/1 THIAMINE MONONITRATE - 4.54 mg/1 VITAMIN D - 400 [iU]/1 ZINC OXIDE - 25 mg/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	11 Apr, 2014
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	23 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Mission Pharmacal Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0301780821305
UPC stands for Universal Product Code.
NUI:	N0000193618 M0001797
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	9E8X80D2L0 PQ6CK8PD0R MLM29U2X85 V1XJQ704R4 F05Q2T2JA0 U1B11I423Z 935E97BOY8 E1UOL152H7 25X51I8RD4 1C4QK22F9J Load more... 68Y4CF58BV TLM2976OFR X66NSO3N35 8K0I04919X 9VU1KI44GP SOI2LOH54Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Vitamin C [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class CS:	Ascorbic Acid [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Analogs/Derivatives [Chemical/Ingredient] Ascorbic Acid [CS] Blood Coagulation Factor [EPC] Calcium [CS] Cations Divalent [CS] Increased Coagulation Factor Activity [PE] Vitamin B 6 [Chemical/Ingredient] Vitamin B6 Analog [EPC] Vitamin C [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
0178-0821-30	6 BLISTER PACK in 1 CARTON (0178-0821-30) / 5 BLISTER PACK in 1 BLISTER PACK / 5 TABLET in 1 BLISTER PACK	11 Apr, 2014	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Citranatal 90 Dha

Vitamin C & more..

Tablet
Mission Pharmacal Company
NDC: 0178-0821

Purpose:

Product Elements:

Citranatal 90 dha vitamin c, calcium, iron, vitamin d3, vitamin e, thiamin, riboflavin, niacinamide, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium ascorbic acid ascorbic acid iron iron .alpha.-tocopherol acetate .alpha.-tocopherol thiamine thiamine ion niacinamide niacinamide pyridoxine hydrochloride pyridoxine folic acid folic acid zinc oxide zinc oxide cupric oxide cupric cation docusate sodium docusate calcium citrate calcium cation calcium citrate thiamine mononitrate thiamine ion thiamine potassium iodide iodide ion ferrous gluconate ferrous cation vitamin d vitamin d riboflavin riboflavin caramel cn;90;0821

Boxed Warning:

Warning: accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. keep this product out of the reach of children. in case of accidental overdose, call a doctor or poison control center immediately.

Indications and Usage:

Indications citranatal Â® 90 dha is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

Warnings:

Warning ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and inr. administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. warning: folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin b 12 is deficient.

Dosage and Administration:

Dosage and administration one tablet and one capsule daily or as directed by a physician.

Contraindications:

Contraindications this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Adverse Reactions:

Adverse reactions allergic sensitization has been reported following both oral and parenteral administration of folic acid.

How Supplied:

How supplied six child-resistant blister packs of 5 tablets and 5 capsules each - ndc 0178-0821-30 to report a serious adverse event or obtain product information, call (210) 696-8400. please consult your health care provider with any dietary concerns. 51072r1120 dha capsules manufactured for: mission pharmacal company san antonio, tx usa 78230 1355 prenatal tablets manufactured by: mission pharmacal company san antonio, tx usa 78230 1355 ferr-easeâ¢ dual-iron delivery trademark of mission pharmacal company

Package Label Principal Display Panel:

Citranatal Â® 90 dha carton ndc: 0178-0821-30 label

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.